Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cadrenal Therapeutics Inc CVKD

Healthcare Biotechnology
Cadrenal Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (ESRD), and atrial fibrillation (irregular heartbeat) (AFib). The Company’s lead drug candidate, tecarfarin, is an... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CVKD)

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Accesswire 5 days ago

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients

PR Newswire August 22, 2024

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients

PR Newswire August 20, 2024

Cadrenal Therapeutics to Present at Upcoming Investor Conferences

PR Newswire August 14, 2024

Cadrenal Therapeutics Provides Second Quarter 2024 Corporate Update

PR Newswire August 7, 2024

Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs

PR Newswire August 6, 2024

Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024

PR Newswire July 17, 2024

Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024

PR Newswire June 11, 2024

Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients

PR Newswire June 3, 2024
View More News ››

Opinion & Analysis (NDAQ:CVKD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CVKD)

CVKD.....My take ....FWIW

This up-coming meeting with FDA could prov to be a major catalyst Caution is needed This has to hold ~ $9.20 or I will say somebody...
Iseneschal - 3 days ago

CVKD....LoL my timing is impeccable....R u watching the dip?

now at $10.05 and Green to Red move Cheers !
Iseneschal - 3 days ago

CVKD,,,,$12.00 Holla !!!!

Low volume runner.....I'm out ; ) Sold to America
Iseneschal - 3 days ago

CVKD......I call this daily action "Walkin the Dog"

Now over $11 which is the highest price since the recent Reverse Split....just sayin Up coming meeting with FDA
Iseneschal - 3 days ago

Type B FDA Meeting....FYI

What are Type B FDA meetings?     ...
Iseneschal - August 22, 2024

RE:CVKD....I hope u all realize this is going to rip to......

Read the previous post which has the todays News Release. Cheers !
Iseneschal - August 22, 2024
View more Bullboard ››

Ciscom Corp.

Ciscom Corp.

Ciscom Corp. is a Canada-based holding (roll-up) company. The Company is acquiring and managing companies in the information ...
View More »